Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Quasthoff, S; Möckel, C; Zieglgänsberger, W; Schreibmayer, W.
Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.
CNS Neurosci Ther. 2008; 14(2): 107-119.
Doi: 10.1111/j.1527-3458.2008.00044.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Quasthoff Stefan
- Schreibmayer Wolfgang
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Tolperisone, a piperidine derivative, is assigned to the group of centrally acting muscle relaxants and has been in clinical use now for decades. The review summarizes the known pharmacokinetics, pharmacodynamics, toxicology and side effects in humans and the clinical use of tolperisone. A future perspective for further exploration of this drug is given.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Clinical Trials as Topic -
- Humans -
- Hypnotics and Sedatives -
- Muscle Relaxants, Central - adverse effects
- Tolperisone - adverse effects
- Find related publications in this database (Keywords)
- stroke
- neuropsychopharmacology
- neuromuscular disease
- movement disorders
- Parkinson's disease
- behavioural neurology
- painful muscle spasm